The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19

Yıl: 2023 Cilt: 5 Sayı: 2 Sayfa Aralığı: 118 - 126 Metin Dili: İngilizce DOI: 10.36519/idcm.2023.216 İndeks Tarihi: 05-07-2023

The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19

Öz:
Objective: We aimed to investigate the vaccination status and the risk factors for the in- tensive care unit (ICU) support need of the laboratory-confirmed breakthrough COVID-19 infection inpatients. Materials and Methods: This multi-center point-prevalence study was conducted on inpa- tients, divided into two groups as ‘fully’ and ‘partially’ vaccinated according to COVID-19 vaccination status. Results: Totally 516 patients were included in the study. The median age was 65 (55-77), and 53.5% (n=276) of the patients were male. Hypertension (41.9%, n=216), diabetes mel- litus (DM) (31.8%, n=164), and coronary artery disease (CAD) (16.3%, n=84) were the pre- dominant comorbidities. Patients were divided into two groups ICU (n=196) and non-ICU (n=301). Hypertension (p=0.026), DM (p=0.048), and congestive heart failure (CHF) (p=0.005) were significantly higher in ICU patients and the median age was younger among non-ICU patients (p=0.033). Of patients, 16.9% (n=87) were fully vaccinated, and this group’s need for ICU support was statistically significantly lower (p=0.021). Conclusion: We conclude that older age, hypertension, DM, CHF, and being partially vacci- nated were associated with the need for ICU support. Therefore, all countries should con- tinuously monitor post-vaccination breakthrough COVID-19 infections to determine the national booster vaccine administration approach that will provide vulnerable individuals the highest protection.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1 Cheng H, Peng Z, Luo W, Si S, Mo M, Zhou H, et al. Efficacy and safety of COVID-19 vaccines in phase III trials: A meta-analy- sis. Vaccines (Basel). 2021;9(6):582. [CrossRef]
  • 2 Acil Kullanım Onayı Duyurusu [Internet]. Ankara: Repub- lic of Turkey Ministry of Health, Turkish Medicines and Medical Devices Agency. [cited January 22, 2023]. Available from:https://www.titck.gov.tr/haber/kamuoyunun-dikka- tine-13012021185623
  • 3 BioNTech aşısı uygulanmaya başlandı [Internet]. Ankara: TRT Haber Website. [cited January 22, 2023]. Available from: https://www.trthaber.com/haber/gundem/biontech-asi- si-uygulanmaya-baslandi-569556.html
  • 4 Günlük aşı verileri [Internet]. Ankara: Republic of Turkey Min- istry of Health COVID-19 Vaccine Information Platform. [cited January 22, 2023]. Available from: https://covid19asi.saglik.gov.tr/
  • 5 Günlük COVID-19 aşı tablosu [Internet]. Ankara: Republic of Turkey Ministry of Health COVID-19 Vaccine Information Plat- form. [cited January 22, 2023]. Available from: https://covid19. saglik.gov.tr/
  • 6 Thompson MG, Stenehjem E, Grannis S, Ball SW, Naleway AL, Ong TC, et al. Effectiveness of Covid-19 vaccines in ambulato- ry and inpatient care settings. N Engl J Med. 2021;385(15):1355- 71. [CrossRef]
  • 7 Rosenberg ES, Holtgrave DR, Dorabawila V, Conroy M, Greene D, Lutterloh E, et al. New COVID-19 cases and hospitalizations among adults, by vaccination status - New York, May 3-July 25, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(37):1306-11. [CrossRef]
  • 8 Muthukrishnan J, Vardhan V, Mangalesh S, Koley M, Shankar S, Yadav AK, et al. Vaccination status and COVID-19 related mortality: A hospital based cross sectional study. Med J Armed Forces India. 2021;77(Suppl 2):S278-82. [CrossRef]
  • 9 Stay up to date with COVID-19 vaccines [Internet]. Atlanta: Centers for Disease Control and Prevention. [cited January 22, 2023]. Available from: https://www.cdc.gov/coronavi- rus/2019-ncov/vaccines/booster-shot.html#boosterdoses
  • 10 Interim clinical considerations for use of COVID-19 vaccines in the United States [Internet]. Atlanta: Centers for Disease Control and Prevention. [cited January 22, 2023]. Available from: https://www.cdc.gov/vaccines/covid-19/clinical-consid- erations/interim-considerations-us.html
  • 11 Wichaidit M, Nopsopon T, Sunan K, Phutrakool P, Ruchik- achorn P, Wanvarie D, et al. Breakthrough infections, hospital admissions, and mortality after major COVID-19 vaccination profiles: A prospective cohort study. Lancet Reg Health South- east Asia. 2023;8:100106. [CrossRef]
  • 12 Peng Q, Zhou R, Wang Y, Zhao M, Liu N, Li S, et al. Wan- ing immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong. EBioMedicine. 2022;77:103904. [CrossRef]
  • 13 ACIP vaccine recommendations and guidelines: Advisory Committee on Immunization Practices (ACIP) [Internet]. At- lanta: Centers for Disease Control and Prevention. [cited Jan- uary 22, 2023]. Available from: https://www.cdc.gov/vaccines/ hcp/acip-recs/vaccspecific/covid-19.html
  • 14 COVID-19 aşısı [Internet]. Ankara: Republic of Turkey Ministry of Health COVID-19 Vaccine Information Platform. [cited Jan- uary 22, 2023]. Available from: https://covid19asi.saglik.gov.tr/ TR-77693/covid-19-asisi.html
  • 15 COVID-19 treatment guidelines: Clinical spectrum of SARS- CoV-2 infection [Internet]. Bethesda: National Institutes of Health (NIH). [cited January 22, 2023]. Available from: https:// www.covid19treatmentguidelines.nih.gov/overview/clini- cal-spectrum/
  • 16 Liu C, Lee J, Ta C, Soroush A, Rogers JR, Kim JH, et al. Risk fac- tors associated with SARS-CoV-2 breakthrough ınfections in fully mRNA-vaccinated ındividuals: Retrospective analysis. JMIR Public Health Surveill. 2022;8(5):e35311. [CrossRef]
  • 17 Pormohammad A, Zarei M, Ghorbani S, Mohammadi M, Aghayari Sheikh Neshin S, Khatami A, et al. Effectiveness of COVID-19 vaccines against delta (B.1.617.2) variant: A system- atic review and meta-analysis of clinical studies. Vaccines (Ba- sel). 2021;10(1):23. [CrossRef]
  • 18 Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. Neutralizing antibody levels are highly predic- tive of immune protection from symptomatic SARS-CoV-2 in- fection. Nat Med. 2021;27(7):1205-11. [CrossRef]
  • 19 Zeng G, Wu Q, Pan H, Li M, Yang J, Wang L, et al. Immunoge- nicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: inter - im results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. Lancet Infect Dis. 2022;22(4):483-95. [CrossRef]
  • 20 Mahase E. Covid-19: How many variants are there, and what do we know about them? BMJ. 2021;374:n1971. [CrossRef]
  • 21 Toker İ, Kılınç Toker A, Turunç Özdemir A, Çelik İ, Bol O, Bülbül E. Vaccination status among patients with the need for emer - gency hospitalizations related to COVID-19. Am J Emerg Med. 2022;54:102-6. [CrossRef]
  • 22 Vo AD, La J, Wu JT, Strymish JM, Ronan M, Brophy M, et al. Factors associated with severe COVID-19 among vaccinated adults treated in US veterans affairs hospitals. JAMA Netw Open. 2022;5(10):e2240037. [CrossRef]
  • 23 Hacisuleyman E, Hale C, Saito Y, Blachere NE, Bergh M, Conlon EG, et al. Vaccine breakthrough infections with SARS-CoV-2 variants. N Engl J Med. 2021;384(23):2212-8. [CrossRef]
  • 24 Brosh-Nissimov T, Orenbuch-Harroch E, Chowers M, El- baz M, Nesher L, Stein M, et al. BNT162b2 vaccine break- through: clinical characteristics of 152 fully vaccinated hos- pitalized COVID-19 patients in Israel. Clin Microbiol Infect. 2021;27(11):1652-7. [CrossRef]
  • 25 Kamuoyu Bilgilendirmesi [Internet]. Ankara: Republic of Turkey Ministry of Health General Directorate of Public Health [cited January 22, 2023] Available from: https://hsgm- destek.saglik.gov.tr/tr/mikrobiyoloji-haberler/kamuoyu-bilg- ilendirmesi.html
  • 26 Zhang M, Liang Y, Yu D, Du B, Cheng W, Li L, et al. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Del- ta Variant. Int J Biol Sci. 2022;18(2):889-900. [CrossRef]
  • 27 Thompson MG, Natarajan K, Irving SA, Rowley EA, Griggs EP, Gaglani M, et al. Effectiveness of a third dose of mRNA vac- cines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant predomi- nance - VISION Network, 10 States, August 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(4):139-45. [CrossRef]
  • 28 Zee ST, Kwok LF, Kee KM, Fung LH, Luk WP, Chan TL, et al. Im- pact of COVID-19 vaccination on healthcare worker infection rate and outcome during SARS-CoV-2 omicron variant out- break in Hong Kong. Vaccines (Basel). 2022;10(8):1322. [Cross- Ref]
APA Yildiz Y, Ozger H, Acar A, Seremet keskin A, Binay U, ünlü G, Bayram H, Asan A, Akça M, Karamanlıoğlu D, İNAN O, Kaya S, Yildirim C, ARSLAN Y, komur s, Saygideger Y, Kandemir Ö, Yasar S, Akdemir Kalkan İ, tekin taş z, Sakız A, BAYINDIR Y, OZER A, mete a, EROL Ç, MERMUTLUOĞLU Ç, KADİROĞLU A, Azap A, ŞENOL E, Diseases T (2023). The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19. , 118 - 126. 10.36519/idcm.2023.216
Chicago Yildiz Yesim,Ozger H.Selcuk,Acar Ali,Seremet keskin Ayşegül,Binay Umut Devrim,ünlü Gülten,Bayram Halim,Asan Ali,Akça Mustafa Özgür,Karamanlıoğlu Dilek,İNAN OSMAN,Kaya Safak,Yildirim Cigdem,ARSLAN YUSUF,komur suheyla,Saygideger Yasemin,Kandemir Özlem,Yasar Simge,Akdemir Kalkan İrem,tekin taş zeynep,Sakız Ayşe,BAYINDIR Yasar,OZER Ayse Belin,mete ayşe özlem,EROL ÇİĞDEM,MERMUTLUOĞLU ÇİĞDEM,KADİROĞLU Ali Kemal,Azap Alpay,ŞENOL ESİN,Diseases The Adult Immunization Study Group of the Turkish Society of Clinical Microbiology and Infectious The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19. (2023): 118 - 126. 10.36519/idcm.2023.216
MLA Yildiz Yesim,Ozger H.Selcuk,Acar Ali,Seremet keskin Ayşegül,Binay Umut Devrim,ünlü Gülten,Bayram Halim,Asan Ali,Akça Mustafa Özgür,Karamanlıoğlu Dilek,İNAN OSMAN,Kaya Safak,Yildirim Cigdem,ARSLAN YUSUF,komur suheyla,Saygideger Yasemin,Kandemir Özlem,Yasar Simge,Akdemir Kalkan İrem,tekin taş zeynep,Sakız Ayşe,BAYINDIR Yasar,OZER Ayse Belin,mete ayşe özlem,EROL ÇİĞDEM,MERMUTLUOĞLU ÇİĞDEM,KADİROĞLU Ali Kemal,Azap Alpay,ŞENOL ESİN,Diseases The Adult Immunization Study Group of the Turkish Society of Clinical Microbiology and Infectious The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19. , 2023, ss.118 - 126. 10.36519/idcm.2023.216
AMA Yildiz Y,Ozger H,Acar A,Seremet keskin A,Binay U,ünlü G,Bayram H,Asan A,Akça M,Karamanlıoğlu D,İNAN O,Kaya S,Yildirim C,ARSLAN Y,komur s,Saygideger Y,Kandemir Ö,Yasar S,Akdemir Kalkan İ,tekin taş z,Sakız A,BAYINDIR Y,OZER A,mete a,EROL Ç,MERMUTLUOĞLU Ç,KADİROĞLU A,Azap A,ŞENOL E,Diseases T The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19. . 2023; 118 - 126. 10.36519/idcm.2023.216
Vancouver Yildiz Y,Ozger H,Acar A,Seremet keskin A,Binay U,ünlü G,Bayram H,Asan A,Akça M,Karamanlıoğlu D,İNAN O,Kaya S,Yildirim C,ARSLAN Y,komur s,Saygideger Y,Kandemir Ö,Yasar S,Akdemir Kalkan İ,tekin taş z,Sakız A,BAYINDIR Y,OZER A,mete a,EROL Ç,MERMUTLUOĞLU Ç,KADİROĞLU A,Azap A,ŞENOL E,Diseases T The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19. . 2023; 118 - 126. 10.36519/idcm.2023.216
IEEE Yildiz Y,Ozger H,Acar A,Seremet keskin A,Binay U,ünlü G,Bayram H,Asan A,Akça M,Karamanlıoğlu D,İNAN O,Kaya S,Yildirim C,ARSLAN Y,komur s,Saygideger Y,Kandemir Ö,Yasar S,Akdemir Kalkan İ,tekin taş z,Sakız A,BAYINDIR Y,OZER A,mete a,EROL Ç,MERMUTLUOĞLU Ç,KADİROĞLU A,Azap A,ŞENOL E,Diseases T "The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19." , ss.118 - 126, 2023. 10.36519/idcm.2023.216
ISNAD Yildiz, Yesim vd. "The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19". (2023), 118-126. https://doi.org/10.36519/idcm.2023.216
APA Yildiz Y, Ozger H, Acar A, Seremet keskin A, Binay U, ünlü G, Bayram H, Asan A, Akça M, Karamanlıoğlu D, İNAN O, Kaya S, Yildirim C, ARSLAN Y, komur s, Saygideger Y, Kandemir Ö, Yasar S, Akdemir Kalkan İ, tekin taş z, Sakız A, BAYINDIR Y, OZER A, mete a, EROL Ç, MERMUTLUOĞLU Ç, KADİROĞLU A, Azap A, ŞENOL E, Diseases T (2023). The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19. Infectious diseases and clinical microbiology (Online), 5(2), 118 - 126. 10.36519/idcm.2023.216
Chicago Yildiz Yesim,Ozger H.Selcuk,Acar Ali,Seremet keskin Ayşegül,Binay Umut Devrim,ünlü Gülten,Bayram Halim,Asan Ali,Akça Mustafa Özgür,Karamanlıoğlu Dilek,İNAN OSMAN,Kaya Safak,Yildirim Cigdem,ARSLAN YUSUF,komur suheyla,Saygideger Yasemin,Kandemir Özlem,Yasar Simge,Akdemir Kalkan İrem,tekin taş zeynep,Sakız Ayşe,BAYINDIR Yasar,OZER Ayse Belin,mete ayşe özlem,EROL ÇİĞDEM,MERMUTLUOĞLU ÇİĞDEM,KADİROĞLU Ali Kemal,Azap Alpay,ŞENOL ESİN,Diseases The Adult Immunization Study Group of the Turkish Society of Clinical Microbiology and Infectious The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19. Infectious diseases and clinical microbiology (Online) 5, no.2 (2023): 118 - 126. 10.36519/idcm.2023.216
MLA Yildiz Yesim,Ozger H.Selcuk,Acar Ali,Seremet keskin Ayşegül,Binay Umut Devrim,ünlü Gülten,Bayram Halim,Asan Ali,Akça Mustafa Özgür,Karamanlıoğlu Dilek,İNAN OSMAN,Kaya Safak,Yildirim Cigdem,ARSLAN YUSUF,komur suheyla,Saygideger Yasemin,Kandemir Özlem,Yasar Simge,Akdemir Kalkan İrem,tekin taş zeynep,Sakız Ayşe,BAYINDIR Yasar,OZER Ayse Belin,mete ayşe özlem,EROL ÇİĞDEM,MERMUTLUOĞLU ÇİĞDEM,KADİROĞLU Ali Kemal,Azap Alpay,ŞENOL ESİN,Diseases The Adult Immunization Study Group of the Turkish Society of Clinical Microbiology and Infectious The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19. Infectious diseases and clinical microbiology (Online), vol.5, no.2, 2023, ss.118 - 126. 10.36519/idcm.2023.216
AMA Yildiz Y,Ozger H,Acar A,Seremet keskin A,Binay U,ünlü G,Bayram H,Asan A,Akça M,Karamanlıoğlu D,İNAN O,Kaya S,Yildirim C,ARSLAN Y,komur s,Saygideger Y,Kandemir Ö,Yasar S,Akdemir Kalkan İ,tekin taş z,Sakız A,BAYINDIR Y,OZER A,mete a,EROL Ç,MERMUTLUOĞLU Ç,KADİROĞLU A,Azap A,ŞENOL E,Diseases T The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19. Infectious diseases and clinical microbiology (Online). 2023; 5(2): 118 - 126. 10.36519/idcm.2023.216
Vancouver Yildiz Y,Ozger H,Acar A,Seremet keskin A,Binay U,ünlü G,Bayram H,Asan A,Akça M,Karamanlıoğlu D,İNAN O,Kaya S,Yildirim C,ARSLAN Y,komur s,Saygideger Y,Kandemir Ö,Yasar S,Akdemir Kalkan İ,tekin taş z,Sakız A,BAYINDIR Y,OZER A,mete a,EROL Ç,MERMUTLUOĞLU Ç,KADİROĞLU A,Azap A,ŞENOL E,Diseases T The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19. Infectious diseases and clinical microbiology (Online). 2023; 5(2): 118 - 126. 10.36519/idcm.2023.216
IEEE Yildiz Y,Ozger H,Acar A,Seremet keskin A,Binay U,ünlü G,Bayram H,Asan A,Akça M,Karamanlıoğlu D,İNAN O,Kaya S,Yildirim C,ARSLAN Y,komur s,Saygideger Y,Kandemir Ö,Yasar S,Akdemir Kalkan İ,tekin taş z,Sakız A,BAYINDIR Y,OZER A,mete a,EROL Ç,MERMUTLUOĞLU Ç,KADİROĞLU A,Azap A,ŞENOL E,Diseases T "The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19." Infectious diseases and clinical microbiology (Online), 5, ss.118 - 126, 2023. 10.36519/idcm.2023.216
ISNAD Yildiz, Yesim vd. "The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19". Infectious diseases and clinical microbiology (Online) 5/2 (2023), 118-126. https://doi.org/10.36519/idcm.2023.216